News coverage about Landauer (NYSE:LDR) has trended somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Landauer earned a news impact score of 0.00 on Accern’s scale. Accern also assigned media coverage about the scientific and technical instruments company an impact score of 45.672346107614 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Shares of Landauer (NYSE:LDR) opened at $67.20 on Wednesday. The company has a quick ratio of 1.87, a current ratio of 2.02 and a debt-to-equity ratio of 3.26. The stock has a market capitalization of $647.71, a PE ratio of 35.00 and a beta of 1.28. Landauer has a 12-month low of $41.00 and a 12-month high of $68.50.
Separately, Zacks Investment Research raised Landauer from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 11th.
Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.
Receive News & Ratings for Landauer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer and related companies with MarketBeat.com's FREE daily email newsletter.